|
1
|
Hinchey J, Chaves C, Appignani B, Breen J,
Pao L, Wang A, Pessin MS, Lamy C, Mas JL and Caplan LR: A
reversible posterior leukoencephalopathy syndrome. N Engl J Med.
334:494–500. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chow S, Cheung CS, Lee DH, Howson-Jan K
and Xenocostas A: Posterior reversible encephalopathy syndrome in a
patient with multiple myeloma treated with thalidomide. Leuk
Lymphoma. 53:1003–1005. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Helissey C, Chargari C, Lahutte M, Ricard
D, Vedrine L, Ceccaldi B and Le Moulec S: First case of posterior
reversible encephalopathy syndrome associated with vinflunine.
Invest New Drugs. 30:2032–2034. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olascoaga Hualde J, Castiella Molins T,
Hernández Souto S, Moreno Becerril F, Petri Yoldi ME, de Sagaseta
Ilurdoz M and Molina Garicano J: Reversible posterior
leukoencephalopathy: Report of two cases after vincristine
treatment. An Pediatr (Barc). 68:282–285. 2008.(In Spanish).
PubMed/NCBI
|
|
5
|
Ito Y, Arahata Y, Goto Y, Hirayama M,
Nagamutsu M, Yasuda T, Yanagi T and Sobue G: Cisplatin
neurotoxicity presenting as reversible posterior
leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 19:415–417.
1998.PubMed/NCBI
|
|
6
|
Patel A, Ayto R and MacDonald DH:
Posterior reversible encephalopathy after intrathecal methotrexate
therapy in diffuse large B-cell lymphoma. Br J Haematol.
161:6072013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rathi B, Azad RK, Vasudha N, Hissaria P,
Sawlani V and Gupta RK: L-asparaginase-induced reversible posterior
leukoencephalopathy syndrome in a child with acute lymphoblastic
leukemia. Pediatr Neurosurg. 37:203–205. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saito B, Nakamaki T, Nakashima H, Usui T,
Hattori N, Kawakami K and Tomoyasu S: Reversible posterior
leukoencephalopathy syndrome after repeat intermediate-dose
cytarabine chemotherapy in a patient with acute myeloid leukemia.
Am J Hematol. 82:304–306. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abali H, Eren OO, Dizdar O, Karadağ O,
Erman M, Yilmaz A, Uluç K, Erdem I and Türker A: Posterior
leukoencephalopathy after combination chemotherapy in a patient
with lymphoma. Leuk Lymphoma. 46:1825–1828. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Allen JA, Adlakha A and Bergethon PR:
Reversible posterior leukoencephalopathy syndrome after
bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch
Neurol. 63:1475–1478. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen H, Modiano MR, Neal JW, Brahmer JR,
Rigas JR, Jotte RM, Leighl NB, Riess JW, Kuo CJ, Liu L, et al: A
phase II multicentre study of ziv-aflibercept in combination with
cisplatin and pemetrexed in patients with previously untreated
advanced/metastatic non-squamous non-small cell lung cancer. Br J
Cancer. 10:602–608. 2014. View Article : Google Scholar
|
|
12
|
Edwards MJ, Walker R, Vinnicombe S, Barlow
C, MacCallum P and Foran JM: Reversible posterior
leukoencephalopathy syndrome following CHOP chemotherapy for
diffuse large B-cell lymphoma. Ann Oncol. 12:1327–1329. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yasaki S, Tukamoto Y, Yuasa N, Ishikawa T
and Yoshii F: Late-onset leukoencephalopathy induced by long-term
chemotherapy with capecitabine and cyclophosphamide for liver
metastasis from breast cancer. Rinsho Shinkeigaku. 52:251–256.
2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sugimoto S, Yamamoto YL, Nagahiro S and
Diksic M: Permeability change and brain tissue damage after
intracarotid administration of cisplatin studied by double-tracer
autoradiography in rats. J Neurooncol. 24:229–240. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edge SB, Byrd DR, Compton CC, et al: Lung.
AJCC Cancer Staging Manual (7th). (New York, NY). Springer.
253–270. 2010.
|
|
16
|
Dersch R, Stich O, Goller K, Meckel S,
Dechent F, Doostkam S, Weiller C and Bardutzky J: Atypical
posterior reversible encephalopathy syndrome associated with
chemotherapy with Bevacizumab, Gemcitabine and Cisplatin. J Neurol.
260:1406–1407. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zahir MN, Masood N and Shabbir-Moosajee M:
Cisplatin-induced posterior reversible encephalopathy syndrome and
successful re-treatment in a patient with non-seminomatous germ
cell tumor: A case report. J Med Case Rep. 6:4092012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kwon EJ, Kim SW, Kim KK, Seo HS and Kim Do
Y: A case of gemcitabine and cisplatin associated posterior
reversible encephalopathy syndrome. Cancer Res Treat. 41:53–55.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maeda T, Kikuchi E, Matsumoto K, Yazawa S,
Hagiuda J, Miyajima A, Nakagawa K, Fujiwara H, Hoshino H and Oya M:
Gemcitabine and cisplatin chemotherapy induced reversible posterior
leukoencephalopathy syndrome in a bladder cancer patient. Int J
Clin Oncol. 15:508–511. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rangi PS, Partridge WJ, Newlands ES and
Waldman AD: Posterior reversible encephalopathy syndrome: A
possible late interaction between cytotoxic agents and general
anaesthesia. Neuroradiology. 47:586–590. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Onujiogu N, Lengyel E and Yamada SD:
Reversible posterior leukoencephalopathy syndrome following
intravenous paclitaxel and intraperitoneal cisplatin chemotherapy
for fallopian tube cancer. Gynecol Oncol. 111:537–539. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paul F, Aktas O, Dieste FJ, Kreitsch P,
Vogel HP and Zipp F: Relapsing reversible posterior
leukoencephalopathy after chemotherapy with cisplatin and
5-fluorouracil. Nervenarzt. 77:706–710. 2006.(In German).
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nomura K, Ohno R, Hamaguchi K, Hata T,
Hatanaka H and Matsuyama H: Clinicopathological report of cisplatin
encephalopathy. Rinsho Shinkeigaku. 35:64–69. 1995.(In Japanese).
PubMed/NCBI
|
|
24
|
Perloff D: Hypertension and
pregnancy-related hypertension. Cardiol Clin. 16:79–101. 1998.
View Article : Google Scholar : PubMed/NCBI
|
